Scopes Are Tricky. ASP's New Cycle Is Not.

Advanced Sterilization Products launches the ULTRA GI Cycle for STERRAD sterilizers, targeting endoscope safety gaps across Australia and Europe

12 Jun 2026

Advanced Sterilization Products introduced the ULTRA GI Cycle for its STERRAD sterilizers in January 2026, targeting a recognised weakness in how hospitals process heat-sensitive endoscopes. The launch coincides with growing regulatory pressure across several markets to raise standards for instrument reprocessing.

Endoscopes present a specific sterilization challenge. Their narrow internal channels are difficult to reach with conventional methods, and failures in reprocessing have been linked to patient infections in multiple countries. The new cycle was designed to address that directly.

Australia and several European health systems have expressed interest in the technology. Both regions have faced rising procedure volumes and tightening compliance requirements, factors that have accelerated demand for validated, device-specific sterilization solutions.

Faster cycle times are among the practical advantages cited by the company. Shorter instrument turnaround reduces downtime between procedures, allowing facilities to handle greater patient throughput without relaxing safety protocols.

The broader sterilization services market continues to expand, shaped by aging populations, more frequent endoscopic procedures, and closer scrutiny of reprocessing practices by regulators. Advanced Sterilization Products is seeking to establish a clear position in that segment with a product built around one of the field's more persistent technical problems.

Whether the ULTRA GI Cycle accelerates wider adoption of device-specific sterilization across other instrument categories remains to be seen, though analysts expect the company's market footprint to grow through 2027.